Demographics in patients included in study
| Gender | Age range* | Any comorbidities | Indication for intravenous antibiotic therapy | Week of treatment | |
| P1 | F | 51–60 | No | Spinal infection – bone and joint | Third week |
| P2 | M | 41–50 | No | Osteomyelitis in finger | End of first week |
| P3 | F | 31–40 | Type 1 diabetic | Discitis | Second week |
| P4 | M | 21–30 | No | Knee septic arthritis | Third week |
| P5 | F | 61–70 | No | Hip prosthetic joint infection | Third week |
| P6 | M | 61–70 | No | Cellulitis in leg | Second week |
| P7 | M | 71–80 | No | Osteomyelitis in toe | Third week |
| P8 | M | 61–70 | No | Knee infection following total replacement | Third week |
| P9 | M | 71–80 | No | Osteomyelitis in toe | Second week |
| P10 | F | 61–70 | No | Osteomyelitis in tibia | Second week |
| P11 | M | 71–80 | Type 1 diabetic | Cellulitis in leg | Second week |
| P12 | M | 41–50 | No | Cellulitis and bursitis in elbow | Second week |
| P13 | M | 61–70 | Liver cirrhosis (non-alcoholic) | Lung disease—Mycobacterium infection | Sixth week |
| P14 | F | 61–70 | No | Osteomyelitis in toe | Fifth week |
| P15 | M | 31–40 | No | Infective endocarditis | Second week |
| P16 | M | 61–70 | Type 2 diabetic | Infected cannula site – cellulitis | Second week |
| P17 | M | 41–50 | No | Discitis | Third week |
| P18 | M | 17–18 | No | Infective endocarditis | Third week |
| P19 | F | 41–50 | No | Cellulitis in leg | Second week |
| P20 | F | 51–60 | No | Cellulitis in leg | Third week |
*The participant age have been reported in age ranges to ensure patient is not identifiable.
F, female; M, male.